InsiderTrades

Form 4 for ANRO Alto Neuroscience, Inc.

Accepted 2024-02-07 00:00:00 ET · period of report 2024-02-06 · accession 0001415889-24-002936 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2024-02-07 2024-02-06 ANRO Savitz Adam Chief MEDICAL Off P - Purchase $16.00 +17.0K 24.9K +217% +$272.0K
DI 2024-02-07 2024-02-06 ANRO Savitz Adam Chief MEDICAL Off C - Cnv Deriv — +7,851 7,851 New —
DI 2024-02-07 2024-02-06 ANRO Savitz Adam Chief MEDICAL Off C - Cnv Deriv $0.00 -16.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-06 P A 17,000 $16.00 24,851 I By Trust — — (F2) The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust.
2 Common Common Stock 2024-02-06 C A 7,851 — 7,851 I By Trust — — (F1) Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date. (F2) The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust.
3 Derivative Series B Preferred Stock 2024-02-06 C D 16,666 $0.00 0 I By Trust — · — to — 7,851 Common Stock (F2) The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust. (F1) Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date.